Zobrazeno 1 - 10
of 14
pro vyhledávání: '"C, Bocanegra Martín"'
Autor:
JI Ynfante Milá, E Rodriguez Molins, IM Carrión Madroñal, E Sánchez Gómez, MB Contreras Rey, C. Bocanegra Martín
Publikováno v:
Eur J Hosp Pharm
Background Compounded sterile drugs have to be prepared in appropriate conditions that ensure their safety in order to prevent medication error and avoid patient harm. Purpose To analyse risks associated with preparation of intravitreal injections (a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61400519e5eecfac36d4394ec7caf5bd
https://europepmc.org/articles/PMC7535308/
https://europepmc.org/articles/PMC7535308/
Autor:
MA Bolivar Raya, C. Bocanegra Martín, J Estaire Gutierrez, MB Contreras Rey, MM Romero Alonso, R Sánchez del Moral
Publikováno v:
Eur J Hosp Pharm
Background The development of new direct acting antivirals (DAAs) for hepatitis C virus (HCV) represents an evolution in the treatment. As HIV-HCV coinfection is common, evaluation of DAAs’ effectiveness and drug interactions with antiretroviral th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76d4bc4112bd4cfe9a3e5f66e9fea357
https://doi.org/10.1136/ejhpharm-2018-eahpconf.400
https://doi.org/10.1136/ejhpharm-2018-eahpconf.400
Autor:
MB Contreras Rey, E Sánchez Gómez, C. Bocanegra Martín, IM Carrión Madroñal, D Yáñez Feria, M.T. Garrido Martínez
Publikováno v:
Eur J Hosp Pharm
Background Eribulin has been approved for locally advanced or metastatic breast cancer after at least one previous chemotherapy regimen for advanced disease, including an anthracycline and a taxane. Purpose To evaluate the effectiveness and safety of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76f9646abaefc37dafce2722886665cc
https://doi.org/10.1136/ejhpharm-2018-eahpconf.216
https://doi.org/10.1136/ejhpharm-2018-eahpconf.216
Autor:
CM Valencia Soto, R Sánchez del Moral, E Sánchez Gómez, MI Sierra Torres, C. Bocanegra Martín, Toscano Guzmán
Publikováno v:
Clinical pharmacy.
Background Thromboembolic disease (TED) is a complex condition in which the interaction between genetic, acquired and environmental factors determines the onset of an episode. Purpose This study aimed to assess the risk factors (RF) associated with T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e48e5ff1880b8e69fd305e32d106403
https://doi.org/10.1136/ejhpharm-2017-000640.156
https://doi.org/10.1136/ejhpharm-2017-000640.156
Autor:
C. Bocanegra Martín, R Sánchez del Moral, E. Pujol de la Llave, L. González Rivas, E Sánchez Gómez, S. Grutzmancher Saiz
Publikováno v:
Farmacia Hospitalaria (English Edition). 35:317-321
Objective: To describe the efficacy, safety, compliance and cost savings of lopinavir/ritonavir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e905ff4f18d0004777374a259d6f0fd
https://doi.org/10.1016/j.farmae.2011.01.001
https://doi.org/10.1016/j.farmae.2011.01.001
Autor:
C. Bocanegra Martín, L.C. Fernández Lisón, A. Hevia Alonso, M.T. Garrido Martínez, E. Pujol de la Llave
Publikováno v:
Farmacia Hospitalaria. 29:11-17
Resumen Objetivos Evaluar los regimenes en pacientes no pretratados de tenofovir + lamivudina + efavirenz versus zidovudina + lamivudina + efavirenz mediante un estudio coste-eficacia. Metodos Se diseno un arbol de decisiones. Se estimo la eficacia a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc16853a485e17688abb51b6f5eb8466
https://doi.org/10.1016/s1130-6343(05)73630-8
https://doi.org/10.1016/s1130-6343(05)73630-8
Autor:
MB Contreras Rey, M Alcalá Galán, E Rodriguez Molins, C. Bocanegra Martín, D Yáñez Feria, E Sánchez Gómez
Publikováno v:
European Journal of Hospital Pharmacy. 23:A224.3-A225
Background Zolpidem is used for the short term treatment of insomnia. Recently, new recommendations about its normal recommended daily dose have been published: 10 mg in adults and 5 mg in older patients and those with reduced liver function, in orde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9c7e88d97bc7172f7b63c8a1790f504
https://doi.org/10.1136/ejhpharm-2016-000875.509
https://doi.org/10.1136/ejhpharm-2016-000875.509
Autor:
L C, Fernández Lisón, E, Pujol de la Llave, A, Hevia Alonso, M T, Garrido Martínez, C, Bocanegra Martín
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 29(1)
To assess tenofovir + lamivudine + efavirenz versus zidovudine + lamivudine + efavirenz in treatment-naive patients using a cost-effectiveness analysis.A decision tree was designed. Effectiveness was estimated from clinical trials. Viral load and CD4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::64c498615f2f2b03ce45c5207f41d777
https://pubmed.ncbi.nlm.nih.gov/15773797
https://pubmed.ncbi.nlm.nih.gov/15773797
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.